Urinary ethylglucuronide assessment in patients treated with disulfiram: A tool to improve verification of abstention and safety

Clinical Neuropharmacology

Volumn 33, Issue 6, 2010, Pages 285-287

  Mutschler, Jochen ^a,b   Grosshans, Martin ^b   Koopmann, Anne ^b   Mann, Karl ^b   Kiefer, Falk ^b   Hermann, Derik ^b  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

acetaldehyde; alcoholism; disulfiram; ethylglucuronide; pharmacology; treatment

Indexed keywords

DISULFIRAM; ETHYL GLUCURONIDE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BREATH ANALYSIS; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RELAPSE; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME; URINALYSIS; URINE LEVEL;

ADULT; AGED; ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIRECTLY OBSERVED THERAPY; DISULFIRAM; DRUG INTERACTIONS; DRUG MONITORING; FEMALE; GLUCURONATES; HUMANS; LIMIT OF DETECTION; MALE; MENTAL DISORDERS; MIDDLE AGED; TANDEM MASS SPECTROMETRY; TEMPERANCE;

EID: 78650289146     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181fc9362     Document Type: Article

References (19)

1. Suh JJ, Pettinati HM, Kampman KM, et al. The status of disulfiram: a half of a century later. J Clin Psychopharmacol 2006;26(3):290-302.
2. Mutschler J, Diehl A, Vollmert C, et al. [Recent results in relaps prevention of alcoholism with disulfiram]. Neuropsychiatr 2008;22(4): 243-251.
3. Diehl A, Ulmer L, Mutschler J, et al. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients. Alcohol Alcohol 2010;45(3): 271-277.
4. Mutschler J, Buhler M, Diehl A, et al. Disulfiram, an old drug with new potential in the treatment of pathological gambling? Med Hypotheses 2010;74(1):209-210.
5. Gaval-Cruz M, Weinshenker D. Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv 2009;9(4):175-187.
6. Mutschler J, Diehl A, Kiefer F. Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action. J Clin Psychopharmacol 2009;29(1):99-101.
7. Neto D, Lambaz R, Tavares JE. Compliance with aftercare treatment, including disulfiram, and effect on outcome in alcohol-dependent patients. Alcohol Alcohol 2007;42(6):604-609.
8. Tampier L, Quintanilla ME, Israel Y. Tolerance to disulfiram induced by chronic alcohol intake in the rat. Alcohol Clin Exp Res 2008;32(6):937-941.
9. Signorini-Allibe N, Gonthier B, Lamarche F, et al. Chronic consumption of ethanol leads to substantial cell damage in cultured rat astrocytes in conditions promoting acetaldehyde accumulation. Alcohol Alcohol 2005;40(3):163-171.
10. Aberle NS 2nd, Burd L, Zhao BH, et al. Acetaldehyde-induced cardiac contractile dysfunction may be alleviated by vitamin B1 but not by vitamins B6 or B12. Alcohol Alcohol 2004;39(5):450-454.
11. Ren J, Brown RA. Influence of chronic alcohol ingestion on acetaldehyde-induced depression of rat cardiac contractile function. Alcohol Alcohol 2000;35(6):554-560.
12. Tyulina OV, Prokopieva VD, Dodd RD, et al. In vitro effects of ethanol, acetaldehyde and fatty acid ethyl esters on human erythrocytes. Alcohol Alcohol 2002;37(2):179-186.
13. Hoiseth G, Bernard JP, Stephanson N, et al. Comparison between the urinary alcohol markers EtG, EtS, and GTOL/5-HIAA in a controlled drinking experiment. Alcohol Alcohol 2008;43(2):187-191.
14. Wurst FM, Dursteler-MacFarland KM, Auwaerter V, et al. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports. Alcohol Clin Exp Res 2008;32(9):1552-1557.
15. Wurst FM, Metzger J. The ethanol conjugate ethyl glucuronide is a useful marker of recent alcohol consumption. Alcohol Clin Exp Res 2002;26(7):1114-1119.
16. Wurst FM, Vogel R, Jachau K, et al. Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Alcohol Clin Exp Res 2003;27(3):471-476.
17. Wurst FM, Alling C, Aradottir S, et al. Emerging biomarkers: new directions and clinical applications. Alcohol Clin Exp Res 2005;29(3):465-473.
18. Wojcik MH, Hawthorne JS. Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence. Alcohol Alcohol 2007;42(4):317-320.
19. Mutschler J, Grosshans M, Koopmann A, et al. Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorderYa case series. Alcohol Alcohol 2010;45(2):146-150.